NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Categories: heart disease

2 8/4/2016

Fish oil after a heart attack: TIME misses the mark by leaving out harms, study limitations

1 7/12/2016

‘This is a game changer:’ Reuters story on new dissolvable stent borders on giddy

7/12/2016

AP takes pains to point out lack of long-term data for new dissolvable stent

6/30/2016

Texting to ‘prevent heart attacks:’ WSJ overstates scope of study

5 4/14/2016

Solid effort by NBC on saturated fat study, though story lacked hard numbers on findings

1/8/2016

US News “Best Diets” release rehashed as HealthDay story

11/10/2015

Get paid to take your pills? Strong Inquirer report covers all the ins and outs

7/17/2015

Costs and risks spelled out clearly in NBC report on statins

7/17/2015

Comprehensive coverage of two new statin studies

1 7/10/2015

Business story on Entresto, newly approved heart failure drug, capably covers most of the health implications